Letter/Communication
CRISPR/Cas9-Edited Gene Therapy for Sickle Cell Disease
NEJM journal watch. Oncology & hematology
09/11/2023
Abstract
CRISPR/Cas9-edited gene therapy could be an emerging option for the treatment of SCD, although cure is still far from realization.
Details
- Title: Subtitle
- CRISPR/Cas9-Edited Gene Therapy for Sickle Cell Disease
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 09/11/2023
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984463081502771
Metrics
11 Record Views